The funds, according to Almouneer, will be used to develop and scale DRU app, the startup's healthtech platform that is used for lifestyle and diabetes management. Furthermore, the company is actively considering expanding its product offerings into adjacent markets within Africa and the Middle East. “We have many patients from Africa and the Middle East that come to Egypt for treatment because of two things. “We are excited to work alongside them as they leverage their specialized expertise across business-building and chronic care to tackle a prevalent health issue across the Middle East and Africa. On its mission to become the lifelong companion of diabetic patients in the region, Almouneer is a unique and necessary innovation.”

Source: The North Africa Journal October 31, 2023 16:16 UTC